¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"half normal solution"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® half-life ÇÑ±Û ¹Ý°¨±â
¼³¸í   
  ¾î¶² ¹°ÁúÀÌ ¿ÜºÎÀû ¿äÀÎ, ¶Ç´Â ³»ºÎÀû ¿äÀο¡ ÀÇÇØ¼­ ºÐÇØµÉ °æ¿ì¿¡ ±× ¹°ÁúÀÇ ¿ø·¡ÀÇ ¾ç¿¡¼­ ¹ÝÀÌ µÇ´Â µ¥ °É¸®´Â ½Ã°£.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • half-normal solution
    ¹Ý±ÔÁ¤¾×
  • half and half nail
    ¹Ý°ú¹Ý¼Õ¹ßÅé
  • half-normal saline
    1/2»ý¸®½Ä¿°¼ö
  • normal saline solution
    »ý¸®½Ä¿°¼ö
  • antibody half-life
    Ç×ü¹Ý°¨±â
  • biologic half-life
    »ý¹°ÇÐÀû¹Ý°¨±â
  • biological half life
    »ý¹°ÇÐÀû¹Ý°¨±â
  • half bath
    ¹Ý½Å¸ñ¿å, ¹Ý½Å¿å
  • half elimination rate
    ¹Ý°¨·ü
  • half shell crown
    ¹Ý±Ý°ü
  • half survival time
    ¹Ý°¨»ýÁ¸½Ã°£
  • half-axial projection
    ¹ÝÃ༺Åõ»ç
  • half-life
    ¹Ý°¨±â
  • half-value layer
    ¹Ý°¡Ãþ
  • normal
    1. Á¤»ó- 2. ³ë¸£¸»
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • half-life
    ¹Ý°¨±â
  • normal distribution
    Á¤±ÔºÐÆ÷
  • normal endometrium
    Á¤»óÀڱ󻸷, Á¤»óÀڱüӸ·
  • normal pressure hydrocephalus
    Á¤»ó¾Ð¼öµÎÁõ
  • normal pressure
    Á¤»ó¾Ð, Ç¥ÁؾÐ
  • normal singleton pregnancy
    Á¤»ó¿Üµ¿ÀÓ½Å
  • normal saline
    »ý¸®½Ä¿°¼ö
  • normal value
    Á¤»óÄ¡
  • solution
    ¿ë¾×
  • balanced salt solution
    ÆòÇü¿°¾×
  • buffer solution
    ¿ÏÃæ¾×
  • hypotonic solution
    ÀúÀå¾×, ³·Àº»ïÅõ¾Ð¿ë¾×
  • Lugol's solution
    ·ç°ñ¿ë¾×
  • physiological salt solution
    »ý¸®½Ä¿°¼ö
  • Ringer's lactate solution
    ¸µ°ÅÁ¥»ê¿ë¾×
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • half-normal solution
    ¹Ý±ÔÁ¤¾×
  • normal oxidizing solution
    ±ÔÁ¤»êÈ­¾×
  • normal saline solution
    (¢¡physiological salt) »ý¸®½Ä¿°¼ö
  • antibody half-life
    Ç×ü¹Ý°¨±â
  • biological half life
    »ý¹°ÇÐÀû¹Ý°¨±â
  • half bath
    ¹Ý½Å¸ñ¿å
  • half shell crown
    ¹Ý±Ý°ü
  • elimination half-life
    ¼Ò½Ç¹Ý°¨±â
  • half-life
    ¹Ý°¨±â
  • half tone
    ¹ÝÀ½
  • half elimination rate
    ¹Ý°¨·ü
  • half survival time
    ¹Ý°¨»ýÁ¸½Ã°£
  • half waking somnambulism
    ¹Ý°¢¼º¸ùÀ¯º´
  • half-value layer
    ¹Ý°¡Ãþ
  • physical half life
    ¹°¸®Àû¹Ý°¨±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • half normal solution
    0.5 ±ÔÁ¤¾×(¡­Ð®ïÒäû).
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • half and half nail
    ¹Ý¹Ý Á¶°©
  • NRC->normal retinal correspondence
    Á¤»ó¸Á¸·´ëÀÀ
  • acute and late normal tissue effects
    Á¤»óÁ¶Á÷ ±Þ¼º¿µÇâ, Á¤»óÁ¶Á÷ ¸¸¼º ¿µÇâ
  • full term normal delivery =FTND
    ¸¸±âÁ¤»óºÐ¸¸(ػѢïáßÈÝÂØ´).
  • full term normal vaginal delivery
    ¸¸±âÁ¤»ó°æÁú½ÄºÐ¸¸.
  • hypothetical normal occlusion
    °¡»óÁ¤»ó±³ÇÕ(Ê£ßÌïáßÈÎáùê).
  • individual normal occlusion
    °³¼ºÁ¤»ó±³ÇÕ (ËÁàõïáßÈÎáùê).
  • antibody half-life
    Ç×ü¹Ý°¨±â(ù÷ô÷ÚâÊïÑ¢).
  • half Fourier imaging
    ¹Ý Fourier ¿µ»ó
  • half bath
    ¹Ý½Å¿å(Úâãóé±).
  • half elimination rate
    1/2Á¦°ÅÀ²(ð¶ËÛëÒ), ¹Ý°¨·ü(ÚâÊõ×Ë)
  • half elimination rate
    1/2Á¦°ÅÀ², ¹Ý°¨·ü.
  • half fat cheese
    ¹ÝÅ»ÁöÄ¡ÀÌÁî.
  • half lethal dose
    ¹ÝÄ¡»ç·®(ÚâöÈÞÝåÖ).
  • half round tube
    ¹Ý¿ø°ü(Úâê­Î·) ±³Á¤¿ë(ÎìïáéÄ) .
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • half normal solution
    0.5 ±ÔÁ¤¾×(¡­Ð®ïÒäû).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • half and half nail
    ¹Ý¹Ý Á¶°©
  • normal oxidizing solution
    ±ÔÁ¤»êÈ­¾×(Юïá ß«ûùäû).
  • normal saline solution
    »ý¸®½Ä¿°¼ö.
  • antibody half-life
    Ç×ü¹Ý°¨±â(ù÷ô÷ÚâÊïÑ¢).
  • biological half life
    ½Å±¤ [¹ÙÀÌ,°£È£]»ý¹°ÇÐÀû ¹Ý°¨±â(¡­ÚâÊõÑ¢).
  • biological half life
    »ý¹°ÇÐÀû ¹Ý°¨±â(¡­ÚâÊõÑ¢)
  • biological half life
    [½ÅÀå,¹ÙÀÌ,°£È£]»ý¹°ÇÐÀû ¹Ý°¨±â(¡­ÚâÊõÑ¢).
  • effective half life
    À¯È¿¹Ý°¨±â.
  • effective half-life
    À¯È¿¹Ý°¨±â
  • elimination half-life
    ¼Ò½Ç¹Ý°¨±â.
  • half Fourier imaging
    ¹Ý Fourier ¿µ»ó
  • half bath
    ¹Ý½Å¿å(Úâãóé±).
  • half elimination rate
    1/2Á¦°ÅÀ²(ð¶ËÛëÒ), ¹Ý°¨·ü(ÚâÊõ×Ë)
  • half elimination rate
    1/2Á¦°ÅÀ², ¹Ý°¨·ü.
  • half fat cheese
    ¹ÝÅ»ÁöÄ¡ÀÌÁî.
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Schaudinn's solution
    »þ¿ìµò°íÁ¤¾×
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • normal-phase chromatgoraphy
    Á¤»ó»ó(ïáßÈßÓ) Å©·Î¸¶Åä±×·¡ÇÇ
  • biological half-life
    »ý¹°ÇÐÀû ¹Ý°¨±â(ßæÚªùÊîÜÚâÊõÑ¢)
  • effective half-life
    À¯È¿ ¹Ý°¨±â(êóüùÚâÊõÑ¢)
  • half-band width
    ¹Ý¶ì ³Êºñ
  • half-cell
    ¹Ý½Ç(Úâãø)
  • half-life
    ¹Ý°¨±â(ÚâÊõÑ¢)
  • half-of-the-sites reactivity
    ¹Ý(Úâ)ÀÚ¸® ¹ÝÀÀ¼º (Úãëëàõ)
  • half-period
    ¹Ý±â°£(ÚâÑ¢Êà)
  • half-reaction
    ¹Ý¹ÝÀÀ(ÚâÚãëë)
  • half-reaction time
    ¹Ý¹ÝÀÀ ½Ã°£(ÚâÚãëëãÁÊà)
  • half-site editing
    ¹Ý(Úâ)ÀÚ¸® ÆíÁý(øºòþ)
  • half-thickness
    ¹Ý°¨(ÚâÊõ) µÎ²²
  • half-time
    ¹Ý ½Ã°£(ÚâãÁÊà)
  • half-value dose
    ¹Ý(Úâ)°ª ¼±·®(àÊÕá)
  • half-value layer
    ¹Ý°¨Ãþ(ÚâÊõöµ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • half-life; half-time
    ¹Ý°¨±â
  • normal range
    Á¤»ó¹üÀ§
  • normal value
    Á¤»óÄ¡, Ç¥ÁØÄ¡, ±ÔÁ¤Ä¡
  • anisotonic solution
    ºñµîÀå¾×
  • replenisher solution
    Áõ¾×
  • s solution
    ¸µ°Å¾×
  • solution
    ¿ë¾×, ¿ë»ó
  • biological half life
    »ý¹°ÇÐÀû¹Ý°¨±â
  • effective half life
    À¯È¿¹Ý°¨±â
  • elimination half-life
    ¼Ò½Ç¹Ý°¨±â
  • half Fourier imaging
    ¹ÝFourier¿µ»ó
  • half lethal dose
    ¹ÝÄ¡»ç·®
  • physical half-life
    ¹°¸®Àû ¹Ý°¨±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
NS natural science; Neosporin; nephrosclerosis; nephrotic syndrome; nervous system; neurological surger...
0.5N half-normal [solution]
N/2 half-normal [solution]
SS disulfide; sacrosciatic; saline soak; saline solution; saliva sample; saliva substitute; Salmonella-...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NSS normal saline solution
HVL 6-half-value layer
FWHM Full width at half maximum
HASTE Half-Fourier Acquisition Single-Shot Turbo Spin Echo
IC50 Half-inhibitory concentrations
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • normal saline solution
    Á¤¼º »ý¸® ½Ä¿°¼ö
  • antibody half-life
    Ç×ü ¹Ý°¨±â
    Ç×ü ºÐÀÚ°¡ Çü¼ºµÈ ÈÄ Æò±Õ »ýÁ¸ÇÏ´Â ½Ã°£À» ÃøÁ¤ÇÏ´Â °ÍÀ¸·Î¼­, º¸Åë µ¿¹°Ã¼³»¿¡¼­ ÀÏÁ¤·®ÀÇ ¸é¿ª ±Û·ÎºÒ¸°ÀÇ 50%¸¦ Á¦°ÅÇÏ´Â µ¥ °É¸®´Â ½Ã°£À¸·Î Ç¥½ÃÇÑ´Ù. ÀÌ ¹Ý°¨±â´Â ¸é¿ª ±Û·ÎºÒ¸°ÀÇ Á¾·ù¿¡ µû¶ó ´Ù¸£´Ù.
  • elimination half-life
    ¼Ò½Ç ¹Ý°¨±â
  • half asleep
    °¡¸é, ¹Ý¼ö¸é
    ¹ÝÀº Àáµé°í ¹ÝÀº ÀáµéÁö ¾ÊÀº »óÅÂ.
  • half impaction of the tooth
    ¹Ý ¸Åº¹Ä¡
    Ä¡¾Æ°¡ ¿ÏÀüÈ÷ ¸ÍÃâµÇÁö ¾Ê°í ¹Ý¸¸ ¸ÍÃâµÇ°í ¹ÝÀº °ñ³»¿¡ ¸Åº¹µÇ¾î ÀÖ´Â Ä¡¾Æ.
  • half round tube
    ¹Ý¿ø °ü
  • half spherical cavity
    ¹Ý±¸Çü ¿Íµ¿
  • half the number
    ¹Ý¼ö
  • half vision
    Çü»ó ½Ã
  • half way house
    Áß°£ÂëÀÇ ÁÖ°Åó, Áß°£ Á¡
    Á¤½Å°ú ȯÀÚ, ¾à¹° Áßµ¶ÀÚ, ¾ËÄÝ Áßµ¶ÀÚ °°Àº ȯÀÚµé Áß ¿ÏÀü ÀÔ¿øÀº ÇÊ¿äÄ¡ ¾ÊÀ¸³ª ±×µéÀÌ °øµ¿ »çȸ¿¡ ´Ù½Ã Á¤ÂøµÇ±â±îÁö ÁߵÀÇ °£È£°¡ ÇÊ¿äÇÑ È¯ÀÚµéÀÇ °ÅÁÖó.
  • half-life of immunoglobulin
    ¸é¿ª ±Û·ÎºÒ¸°ÀÇ ¹Ý°¨±â
  • lower half headache
    ¾È¸é ÇϹݺΠµÎÅë, ÇϹݺΠµÎÅë
  • one : À¯±âÈ­Çп¡¼­ ÄÉÅæÀÌ ÀÖÀ½À» ³ªÅ¸³»´Â Á¢¹Ì¾î.

    one and one-half syndrome

    1°ú 1/2 ÁõÈıº
  • acute and late normal tissue effects£¨Á¤»ó Á¶Á÷ ±Þ¼º ¿µÇ⣩

    acute angle

    ¿¹°¢
    Á÷°¢º¸´Ù ÀÛÀº °¢.
  • citrated normal human plasma
    Á¤»óÀÎ ±¸¿¬»ê¿° ÷°¡ Ç÷Àå
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
half and half nail Division of the nail by a transverse line into a proximal dull white part and a distal pink or brown part; seen in uraemia.
(05 Mar 2000)
beta-normal <radiobiology> Beta-N, the normalised beta, is beta relative to the beta limit.
(09 Oct 1997)
big axillary nodes and normal breasts <radiology> Consider: lymphoma, leukaemia, rheumatoid arthritis
(12 Dec 1998)
gallium uptake with normal chest film <radiology> Pulmonary drug toxicity, tumour infiltration, sarcoidosis, pneumocystis carinii see: lung: gallium imaging
(12 Dec 1998)
range, normal Normal results can fall outside the normal range. By convention, the normal range is set to cover ninety-five percent (95%) of values from a normal population. Five percent (5%) of normal results therefore fall outside the normal range.
(12 Dec 1998)
human normal immunoglobulin A preparation of the proteins of liquid human plasma, containing the antibodies of normal adults; it is obtained from pooled liquid human plasma from a number of donors and may be prepared by precipitation with organic solvents under controlled conditions of pH, ionic strength, and temperature.
Synonym: human normal immunoglobulin.
(05 Mar 2000)
normal <microscopy> An imaginary line forming a right angle with the tangent to a curved surface at a particular point. It is used as a basis for determining angles of incidence, reflection, and refraction.
(05 Aug 1998)
normal animal In research, an experimental animal that has neither suffered an attack of a particular disease nor received an injection of a specific microorganism or its toxin.
(05 Mar 2000)
normal antibody Antibody demonstrable in the serum or plasma of various persons or animals not known to have been stimulated by specific antigen, either artificially or as the result of naturally occurring contact.
Synonym: natural antibody.
(05 Mar 2000)
normal antitoxin Serum that is capable of neutralizing an equivalent quantity of a normal toxin solution.
(05 Mar 2000)
normal bite That arrangement of teeth and their supporting structure which is usually found in health and which approaches an ideal or standard arrangement.
Synonym: normal bite.
Synonym: neutral occlusion.
(05 Mar 2000)
normal butyric acid (also written as n-butyric acid), butanoic acid, CH3CH2CH2COOH, which occurs in combination with glycerol in cow's butter; and isobutyric acid, 2-methylpropanoic acid, (CH3)2CHCOOH, one of the intermediates in valine catabolism, found in combination with glycerol in croton oil and elsewhere.
(05 Mar 2000)
normal cholesteraemic xanthomatosis histiocytosis
normal distribution Continuous frequency distribution of infinite range. Its properties are as follows: 1) continuous, symmetrical distribution with both tails extending to infinity; 2) arithmetic mean, mode, and median identical; and 3) shape completely determined by the mean and standard deviation.
(12 Dec 1998)
normal electrical axis A mean electrical axis of the heart situated between -30
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • normal solution
    ±ÔÁ¤¾×
  • normal
    º¸ÅëÀÇ,Á¤»óÀûÀÎ,Á¤»ó»óÅÂ,Æò±Õ,(OPP.abnormal)
  • normal hours
    º¸Åë ½Ã°£´ë
  • solution
    ÇØ°á
  • Ringer's solution
    ¸µ°Å¾×
  • final solution
    ÃÖÁ¾Àû ÇØ°á
  • fixing solution
    Á¤Âø¾×
  • normal
    Ç¥ÁØÀÇ;±Ô°Ý´ë·ÎÀÇ;Á¤±ÔÀÇ;ÀüÇüÀûÀÎ;Á¤»óÀÇ;»óÅÂÀÇ;º¸ÅëÀÇ;Æò±ÕÀÇ;(»ç¶÷ÀÌ)Á¤»óÀûÀ¸·Î ¹ß´ÞÇϰí ÀÖ´Â;¼öÁ÷ÀÇ;(¿ë¾×ÀÌ)±ÔÁ¤ÀÇ;(½ÇÇ赿¹°ÀÌ)Á¤»óÀÇ;(¸é¿ªµî)ÀÚ¿¬ÀÇ
  • normal
    »óÅÂ;ÀüÇü;Ç¥ÁØ;Æò±Õ;Æò¿Â;¹ý¼±;¼öÁ÷¼±;Æò±Õ·®;normalness()n
  • normal distribution
    Á¤»óºÐÆ÷
  • normal school
    »ç¹üÇб³(ÇöÀç´Â teachers college·Î °³Äª
  • normal temperature
    Æò»óü¿Â
  • physiological salt solution
    »ý¸®Àû ½Ä¿°¼ö o
  • saturated solution
    Æ÷È­ ¿ë¾×
  • solution
    ÇØ°á;ÇØ¸í;¿ëÇØ;¿ë¾×;ºÐ¸®
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á